MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-10-0010325
Serbia Molecules Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹50.76 Lakh
▼ 74% YoY
Net loss · FY 2025
₹53,124
Net margin -1%
EBITDA · FY 2025
₹1.23 Lakh
EBITDA margin 2.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹9 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
4
As per MCA filings
About Serbia Molecules Private Limited
Data last updated:
Serbia Molecules Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100HR2012PTC046341. Its GSTIN is 06AARCS6856J1ZK (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Anil Kumar and Pankaj Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Karnal, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.76 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹53,124 (net margin -1%) and EBITDA of ₹1.23 Lakh (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 24% over five years.
The company is associated with 1 brand: Serbia Molecules. As per MCA filings, the company has open charges of ₹9 Lakh on record.
Serbia Molecules Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0010325). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website serbiamolecules.in.
Company details
CIN U85100HR2012PTC046341
Registration Number 046341
Incorporation Date 25 June 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-10-0010325
Recognitions & Rankings of Serbia Molecules
Contact details
Serbia Molecules Private Limited's registered office is in Karnal, Haryana. Its website is serbiamolecules.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3741/6, Gaushala Road Janak Puri, Karnal, Haryana, India – 132001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Serbia Molecules Private Limited, buy the company report.
Comprehensive company report
Serbia Molecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Serbia Molecules operates one associated brand: Serbia Molecules. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical marketing and PCD company offering products to distributors and franchise partners. | serbiamolecules.in |
Business activity
The main business activity of Serbia Molecules is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Serbia Molecules Private Limited, buy the company report.
Financials of Serbia Molecules Private Limited
FY 2025 filings availableSerbia Molecules Private Limited reported revenue of ₹50.76 Lakh (down 74% YoY) for FY 2025.
Revenue · FY 2025
₹50.76 Lakh ▼ 74%
Net loss · FY 2025
₹53,124 margin -1%
EBITDA · FY 2025
₹1.23 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 74%
3 years · compounded
▼ 36%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 29%
5 years · compounded
▼ 21%
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 74% fall in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹53,124 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Serbia Molecules Private Limited, buy the company report.
Board of directors of Serbia Molecules Private Limited
Serbia Molecules has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar | Director | 25 Jun 2012 | 14 Years 4 Months | Current |
| Pankaj Arora | Director | 25 Jun 2012 | 14 Years 4 Months | Current |
| Sachin Ahuja Also directs: Stenkem Molecules Private Limited | Director | 25 Jun 2012 | 14 Years 4 Months | Current |
| Dinesh Wadhwa | Director | 25 Jun 2012 | 14 Years 4 Months | Current |
Auditor
Serbia Molecules Private Limited is audited by AMIT VED AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT VED AND ASSOCIATES | FY 2023 | 019057N |
Shareholding
The shareholding of Serbia Molecules Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Serbia Molecules Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2013 | 10433872 | State Bank of Patiala | ₹9 Lakh | Open |
To see the full charge records of Serbia Molecules Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Serbia Molecules Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Serbia Molecules Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| G Nine Bioceuticals Private Limited | |||
| Zenact Pharma P Ltd, PKL Ok |
To see the full MSME payment records of Serbia Molecules Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Serbia Molecules has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AARCS6856J1ZK | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Serbia Molecules Private Limited, buy the company report.
Recent activity
Serbia Molecules Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Anil Kumar was appointed as Director on 25 Jun 2012.
AGM
Serbia Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Serbia Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with State Bank Of Patiala of Rs. 9.00 Lakh registered on 27 Jun 2013 with Charge ID 10433872 was modified on 01 Aug 2014.
Charges
A charge with State Bank Of Patiala amounted to Rs. 9.00 Lakh with Charge ID 10433872 was registered on 27 Jun 2013.
Appointed
Anil Kumar was appointed as Director.
Appointed
Dinesh Wadhwa was appointed as Director.
Appointed
Pankaj Arora was appointed as Director.
Appointed
Sachin Ahuja was appointed as Director.
Incorporation
25 Jun 2012
Serbia Molecules Private Limited was registered on 25 Jun 2012 with Roc Delhi & aged 14 years 4 months as per MCA records.
Frequently asked questions
Serbia Molecules is an active private limited company based in Karnal, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 June 2012 (14+ years old) and is registered under CIN U85100HR2012PTC046341.
Serbia Molecules has 4 current directors:
- Anil Kumar - Director
- Pankaj Arora - Director
- Sachin Ahuja - Director
- Dinesh Wadhwa - Director
The latest financial statements of Serbia Molecules on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Serbia Molecules is 06AARCS6856J1ZK, registered in Haryana.
The CIN (Corporate Identification Number) of Serbia Molecules is U85100HR2012PTC046341. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serbia Molecules was incorporated on 25 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Kumar was appointed as Director on 25 Jun 2012. Dinesh Wadhwa was appointed as Director on 25 Jun 2012. Pankaj Arora was appointed as Director on 25 Jun 2012. Serbia Molecules has 4 board changes on record in total.
Yes, Serbia Molecules is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-10-0010325).
Serbia Molecules has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 31 May 2019.
Serbia Molecules can be reached through the website serbiamolecules.in. Its registered office is in Karnal, Haryana, India.
The registered office of Serbia Molecules is at 37416, Gaushala Road Janak Puri, Karnal, Haryana, India – 132001.